107 related articles for article (PubMed ID: 25555733)
1. Synthesis and biological evaluation of isoindoloisoquinolinone, pyroloisoquinolinone and benzoquinazolinone derivatives as poly(ADP-ribose) polymerase-1 inhibitors.
Suyavaran A; Ramamurthy C; Mareeswaran R; Shanthi YV; Selvakumar J; Mangalaraj S; Kumar MS; Ramanathan CR; Thirunavukkarasu C
Bioorg Med Chem; 2015 Feb; 23(3):488-98. PubMed ID: 25555733
[TBL] [Abstract][Full Text] [Related]
2. Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase.
Hattori K; Kido Y; Yamamoto H; Ishida J; Iwashita A; Mihara K
Bioorg Med Chem Lett; 2007 Oct; 17(20):5577-81. PubMed ID: 17804225
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of isoquinolinone-based tricycles as novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Chen J; Peng H; He J; Huan X; Miao Z; Yang C
Bioorg Med Chem Lett; 2014 Jun; 24(12):2669-73. PubMed ID: 24815508
[TBL] [Abstract][Full Text] [Related]
4. [Design, synthesis and biological evaluation of novel para-substituted 1-benzyl-quinazoline-2, 4 (1H, 3H)-diones as human PARP-1 inhibitors].
Yao HP; Zhu ZX; Ji M; Chen XG; Xu BL
Yao Xue Xue Bao; 2014 Apr; 49(4):497-503. PubMed ID: 24974467
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
Hannigan K; Kulkarni SS; Bdzhola VG; Golub AG; Yarmoluk SM; Talele TT
Bioorg Med Chem Lett; 2013 Nov; 23(21):5790-4. PubMed ID: 24074844
[TBL] [Abstract][Full Text] [Related]
6. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.
Jagtap PG; Baloglu E; Southan GJ; Mabley JG; Li H; Zhou J; van Duzer J; Salzman AL; Szabó C
J Med Chem; 2005 Aug; 48(16):5100-3. PubMed ID: 16078828
[TBL] [Abstract][Full Text] [Related]
8. Towards new neuroprotective agents: design and synthesis of 4H-thieno[2,3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitors.
Pellicciari R; Camaioni E; Costantino G; Marinozzi M; Macchiarulo A; Moroni F; Natalini B
Farmaco; 2003 Sep; 58(9):851-8. PubMed ID: 13679179
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Rhee HK; Lim SY; Jung MJ; Kwon Y; Kim MH; Choo HY
Bioorg Med Chem; 2009 Nov; 17(21):7537-41. PubMed ID: 19800803
[TBL] [Abstract][Full Text] [Related]
10. 5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).
Sunderland PT; Woon EC; Dhami A; Bergin AB; Mahon MF; Wood PJ; Jones LA; Tully SR; Lloyd MD; Thompson AS; Javaid H; Martin NM; Threadgill MD
J Med Chem; 2011 Apr; 54(7):2049-59. PubMed ID: 21417348
[TBL] [Abstract][Full Text] [Related]
11. Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure.
Canan Koch SS; Thoresen LH; Tikhe JG; Maegley KA; Almassy RJ; Li J; Yu XH; Zook SE; Kumpf RA; Zhang C; Boritzki TJ; Mansour RN; Zhang KE; Ekker A; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR; Webber SE; Hostomsky Z
J Med Chem; 2002 Nov; 45(23):4961-74. PubMed ID: 12408707
[TBL] [Abstract][Full Text] [Related]
12. On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives.
Pellicciari R; Camaioni E; Costantino G; Formentini L; Sabbatini P; Venturoni F; Eren G; Bellocchi D; Chiarugi A; Moroni F
ChemMedChem; 2008 Jun; 3(6):914-23. PubMed ID: 18409175
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel PARP-1 inhibitors: Drug design, synthesis and biological evaluation.
Xie Z; Zhou Y; Zhao W; Jiao H; Chen Y; Yang Y; Li Z
Bioorg Med Chem Lett; 2015 Oct; 25(20):4557-61. PubMed ID: 26342868
[TBL] [Abstract][Full Text] [Related]
14. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
[TBL] [Abstract][Full Text] [Related]
15. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3.
Lindgren AE; Karlberg T; Thorsell AG; Hesse M; Spjut S; Ekblad T; Andersson CD; Pinto AF; Weigelt J; Hottiger MO; Linusson A; Elofsson M; Schüler H
ACS Chem Biol; 2013 Aug; 8(8):1698-703. PubMed ID: 23742272
[TBL] [Abstract][Full Text] [Related]
16. Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia.
Chiarugi A; Meli E; Calvani M; Picca R; Baronti R; Camaioni E; Costantino G; Marinozzi M; Pellegrini-Giampietro DE; Pellicciari R; Moroni F
J Pharmacol Exp Ther; 2003 Jun; 305(3):943-9. PubMed ID: 12606624
[TBL] [Abstract][Full Text] [Related]
17. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors.
Moree WJ; Goldman P; Demaggio AJ; Christenson E; Herendeen D; Eksterowicz J; Kesicki EA; McElligott DL; Beaton G
Bioorg Med Chem Lett; 2008 Sep; 18(18):5126-9. PubMed ID: 18713665
[TBL] [Abstract][Full Text] [Related]
18. One-pot tandem Hurtley-retro-Claisen-cyclisation reactions in the synthesis of 3-substituted analogues of 5-aminoisoquinolin-1-one (5-AIQ), a water-soluble inhibitor of PARPs.
Woon EC; Sunderland PT; Paine HA; Lloyd MD; Thompson AS; Threadgill MD
Bioorg Med Chem; 2013 Sep; 21(17):5218-27. PubMed ID: 23849206
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.
Tikhe JG; Webber SE; Hostomsky Z; Maegley KA; Ekkers A; Li J; Yu XH; Almassy RJ; Kumpf RA; Boritzki TJ; Zhang C; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR
J Med Chem; 2004 Oct; 47(22):5467-81. PubMed ID: 15481984
[TBL] [Abstract][Full Text] [Related]
20. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
